Seeking Alpha

Shares of Alexza Pharmaceuticals (ALXA) fall off another 16%, and have now given back...

Shares of Alexza Pharmaceuticals (ALXA) fall off another 16%, and have now given back almost all of their gains from Tuesday's rocket ride following FDA approval for Adasuve. An influence on ALXA's share price could be a FDA panel that TheStreet.com's Adam Feurstein calls "confusing."
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)